CXR Atlas

Lung parenchyma · ESR chapter pp.120–124

Lung cancer: imaging, staging & screening

CT detects and stages; PET/CT refines N and M staging; TNM drives treatment through the multidisciplinary tumour board.

Practise this topic (2 questions)

Epidemiology and imaging role

  • Smoking causes ~85% of cases; about 12% of new cases occur in never-smokers, and roughly 65% arise in former or never smokers. Only ~25% survive >5 years overall.
  • CT is the primary tool for detection and staging; PET/CT separates tumour from atelectasis, finds nodal/distant metastases and synchronous cancers.

TNM and the MDT

  • T = tumour size/local invasion; N = nodal involvement (ipsilateral vs contralateral, hilar vs mediastinal); M = distant metastases.
  • Example: tumour >7 cm + contralateral mediastinal nodes + single extrathoracic metastasis → T4 N3 M1b (8th edition).
  • Multidisciplinary tumour boards improve treatment efficacy and outcomes.

Screening

  • Annual low-dose CT in high-risk current/former heavy smokers lowers lung-cancer mortality; CXR screening does not.
  • Limits: false positives, overdiagnosis, radiation, cost and access; VDT is a key parameter in screening follow-up.

Images for this topic

4 images